Health Peresolimab: Phase 2 Study for Rheumatology Treatment by Alexandra Hartman Editor-in-Chief May 18, 2023 written by Alexandra Hartman Editor-in-Chief May 18, 2023 48 2023-05-18 09:14:28 Rheumatology – Phase 2 study Phase 2 study The monoclonal antibody peresolimab restores the immune checkpoint in rheumatoid arthritis. Biomarkers and predictive factors for rheumatoid arthritis continue to be studied. (ILLUSTRATION: Gabriel Sanz) 1684401403 #explore #checkpoint #route #treat #rheumatoid #arthritis Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Discover the Fascinating Würth Collection of Jose de Guimaraes Artwork at Art Room Würth Austria in Böheimkirchen next post “The Godfather Lessons: How the CAQ Party Operates and Will it Survive?” You may also like Universal Nasal Spray Vaccine Shows Promise Against Viruses,... February 24, 2026 Expanded Health Insurance Covers More Chronic Diseases in... February 24, 2026 John Oliver & CBS: Peter Attia Resigns After... February 24, 2026 Awe & Loneliness: Study Links Daily Awe to... February 24, 2026 Bronquiolite: Vaccination & Prevention Updates – Recife, Alagoas... February 24, 2026 Artemis II Moon Mission Delayed Again Due to... February 24, 2026 Alternate Mediterranean Diet: Benefits & Red Meat February 24, 2026 OK Pediatrician Charged in Daughter’s Drowning: 911 Calls... February 24, 2026 Microplastics Found in Prostate Cancer Tumors: Study Raises... February 24, 2026 Diabetes Cases in Tunisia: Shocking Numbers Revealed February 24, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
